Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 1.55
HUM's Cash-to-Debt is ranked higher than
56% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. HUM: 1.55 )
Ranked among companies with meaningful Cash-to-Debt only.
HUM' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.26  Med: 0.98 Max: No Debt
Current: 1.55
Equity-to-Asset 0.32
HUM's Equity-to-Asset is ranked lower than
52% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.34 vs. HUM: 0.32 )
Ranked among companies with meaningful Equity-to-Asset only.
HUM' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.25  Med: 0.39 Max: 0.54
Current: 0.32
0.25
0.54
Interest Coverage 14.35
HUM's Interest Coverage is ranked higher than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.62 vs. HUM: 14.35 )
Ranked among companies with meaningful Interest Coverage only.
HUM' s Interest Coverage Range Over the Past 10 Years
Min: 8.21  Med: 14.43 Max: 20.5
Current: 14.35
8.21
20.5
Beneish M-Score: -3.06
WACC vs ROIC
6.29%
53.99%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % 5.04
HUM's Operating Margin % is ranked lower than
52% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.19 vs. HUM: 5.04 )
Ranked among companies with meaningful Operating Margin % only.
HUM' s Operating Margin % Range Over the Past 10 Years
Min: 2.85  Med: 4.77 Max: 6.07
Current: 5.04
2.85
6.07
Net Margin % 2.71
HUM's Net Margin % is ranked lower than
56% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.19 vs. HUM: 2.71 )
Ranked among companies with meaningful Net Margin % only.
HUM' s Net Margin % Range Over the Past 10 Years
Min: 1.13  Med: 3.05 Max: 3.85
Current: 2.71
1.13
3.85
ROE % 13.76
HUM's ROE % is ranked lower than
61% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.42 vs. HUM: 13.76 )
Ranked among companies with meaningful ROE % only.
HUM' s ROE % Range Over the Past 10 Years
Min: 5.84  Med: 14.85 Max: 23.54
Current: 13.76
5.84
23.54
ROA % 5.24
HUM's ROA % is ranked higher than
56% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.26 vs. HUM: 5.24 )
Ranked among companies with meaningful ROA % only.
HUM' s ROA % Range Over the Past 10 Years
Min: 2.45  Med: 6.27 Max: 8.39
Current: 5.24
2.45
8.39
3-Year Revenue Growth Rate 11.60
HUM's 3-Year Revenue Growth Rate is ranked higher than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. HUM: 11.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
HUM' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -26.1  Med: 10 Max: 28.7
Current: 11.6
-26.1
28.7
3-Year EBITDA Growth Rate -2.20
HUM's 3-Year EBITDA Growth Rate is ranked lower than
84% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.80 vs. HUM: -2.20 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
HUM' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -46.2  Med: 7.65 Max: 38.5
Current: -2.2
-46.2
38.5
3-Year EPS without NRI Growth Rate -19.30
HUM's 3-Year EPS without NRI Growth Rate is ranked lower than
88% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.40 vs. HUM: -19.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
HUM' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -49.7  Med: 5.15 Max: 41.9
Current: -19.3
-49.7
41.9
GuruFocus has detected 7 Warning Signs with Humana Inc $HUM.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» HUM's 30-Y Financials

Financials (Next Earnings Date: 2017-08-02)


Revenue & Net Income
Equity & Asset
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 621610    SIC: 6324
Compare:NAS:ESRX, NYSE:CI, NYSE:ANTX, NYSE:AET, NYSE:CNC, NYSE:WCG, NYSE:MOH, NAS:MGLN, NYSE:UAM, NAS:HIIQ, OTCPK:OPRX, OTCPK:WCUI, NAS:CNXR, NYSE:CVS, NYSE:UNH » details
Traded in other countries:HUM.Germany,
Headquarter Location:USA
Humana Inc is a health care company that offers insurance products and health and wellness services. Its segments include Retail, Employer Group and Healthcare Services.

Humana is one of the largest and best-known providers of Medicare Advantage plans in the U.S. The firm specializes in providing government-sponsored plans, with close to three fourths of its membership tied to Medicare, Medicaid, or some other form of government healthcare program. Humana is also building out an extensive provider network in key geographic areas in order to control the use and cost of healthcare services. These network and the firm's brand name will also make it a major player in the nascent public exchange market.

Top Ranked Articles about Humana Inc

Eaton Vance Worldwide Health Sciences Fund Adds 4 Stocks to Portfolio Health care fund reports fourth-quarter activity
Jason Kritzer, vice president of Eaton Vance Management, invests in companies with a bottom-up, proprietary research approach. The portfolio manager of the Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) invested in four companies during the first quarter: Aetna Inc. (NYSE:AET), Humana Inc. (NYSE:HUM), Hologic Inc. (NASDAQ:HOLX) and Teleflex Inc. (NYSE:TFX) Read more...
Leon Cooperman's Top 5 New Buys Omega Advisers updates first-quarter portfolio
Leon Cooperman (Trades, Portfolio), who leads Omega Advisers, a $3.6 billion firm, purchased 30 new stocks in the first quarter. Read more...
Insiders Sell Amazon, Humana, MasterCard Insiders' largest buys and sales of the week
The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+” the duration to “May 2017” and All Insider Sales to “$5,000,000+.” Read more...
Daniel Loeb’s Value-Seeking Journey This guru investor has gone from being a brash activist to an observer of the really big picture
Over slightly more than two decades, Loeb’s Master Fund has returned average annual returns of 17.9%. Read more...
Analysts Release New Health Care Stock Ratings Jeffries downgrades Amgen to hold from buy
Analysts released new ratings for some health care stocks recently. Read more...
Trump's New Health Care Frontier Will reform have investors looking toward telemedicine?
A Donald Trump presidency has many more eyes focused on health care and the adjustment in health care reform that has been frequently discussed by the president. For investors, this tumultuous time could actually be opening up much greater opportunities not only in the health care sector but also the medical technology and telemedicine industries. Read more...
Daniel Loeb Buys JPMorgan, Time Warner, Bank of America Guru's largest 4th-quarter buys
Daniel Loeb (Trades, Portfolio) founded Third Point LLC in 1995 and leads the firm’s research activities, portfolio and risk management. During the fourth quarter of 2016, he bought shares in the following stocks: Read more...
Insiders Roundup: The Week's Largest Buys and Sales Netflix, American Express, Procter & Gamble top the list
The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “February 2017” and All Insider Sales to “$5,000,000+.” Read more...
Investor Confidence in Cigna and Anthem Rises as Health Care Mergers Dealt Blows Both companies gained as dates for decisions pushed back to Trump administration
As a judge struck down a mega merger between health care giants Aetna (NYSE:AET) and Humana (NYSE:HUM) on Tuesday, investor confidence seemed to grow for two other companies seeking to unite in a similar deal, Cigna (NYSE:CI) and Anthem (NYSE:ANTM). Read more...
Hotchkis & Wiley Trims Corning, Microsoft, Exits HP Firm's largest trades in the 3rd quarter
HOTCHKIS & WILEY was formed in Los Angeles in 1980 and has focused exclusively on finding and owning undervalued companies that have a significant potential for appreciation. During the third quarter the guru’s largest sells were the following: Read more...

Ratios

vs
industry
vs
history
PE Ratio 24.09
HUM's PE Ratio is ranked lower than
68% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.18 vs. HUM: 24.09 )
Ranked among companies with meaningful PE Ratio only.
HUM' s PE Ratio Range Over the Past 10 Years
Min: 4.26  Med: 11.03 Max: 53.01
Current: 24.09
4.26
53.01
Forward PE Ratio 21.19
HUM's Forward PE Ratio is ranked lower than
82% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.39 vs. HUM: 21.19 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 24.09
HUM's PE Ratio without NRI is ranked lower than
67% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.18 vs. HUM: 24.09 )
Ranked among companies with meaningful PE Ratio without NRI only.
HUM' s PE Ratio without NRI Range Over the Past 10 Years
Min: 4.26  Med: 11.03 Max: 53.01
Current: 24.09
4.26
53.01
Price-to-Owner-Earnings 7.12
HUM's Price-to-Owner-Earnings is ranked higher than
82% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.73 vs. HUM: 7.12 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
HUM' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.73  Med: 7.51 Max: 76.26
Current: 7.12
2.73
76.26
PB Ratio 3.34
HUM's PB Ratio is ranked lower than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.78 vs. HUM: 3.34 )
Ranked among companies with meaningful PB Ratio only.
HUM' s PB Ratio Range Over the Past 10 Years
Min: 0.71  Med: 1.8 Max: 3.82
Current: 3.34
0.71
3.82
PS Ratio 0.66
HUM's PS Ratio is ranked lower than
54% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.64 vs. HUM: 0.66 )
Ranked among companies with meaningful PS Ratio only.
HUM' s PS Ratio Range Over the Past 10 Years
Min: 0.11  Med: 0.39 Max: 0.66
Current: 0.66
0.11
0.66
Price-to-Free-Cash-Flow 6.92
HUM's Price-to-Free-Cash-Flow is ranked higher than
82% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.35 vs. HUM: 6.92 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
HUM' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 2.77  Med: 7.3 Max: 669.94
Current: 6.92
2.77
669.94
Price-to-Operating-Cash-Flow 6.28
HUM's Price-to-Operating-Cash-Flow is ranked higher than
80% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.27 vs. HUM: 6.28 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
HUM' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.5  Med: 6.22 Max: 53.04
Current: 6.28
2.5
53.04
EV-to-EBIT 7.85
HUM's EV-to-EBIT is ranked higher than
80% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.25 vs. HUM: 7.85 )
Ranked among companies with meaningful EV-to-EBIT only.
HUM' s EV-to-EBIT Range Over the Past 10 Years
Min: -0.7  Med: 3.6 Max: 14.4
Current: 7.85
-0.7
14.4
EV-to-EBITDA 6.77
HUM's EV-to-EBITDA is ranked higher than
76% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.19 vs. HUM: 6.77 )
Ranked among companies with meaningful EV-to-EBITDA only.
HUM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -0.6  Med: 3.1 Max: 11.4
Current: 6.77
-0.6
11.4
PEG Ratio 10.48
HUM's PEG Ratio is ranked lower than
93% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.82 vs. HUM: 10.48 )
Ranked among companies with meaningful PEG Ratio only.
HUM' s PEG Ratio Range Over the Past 10 Years
Min: 0.15  Med: 0.62 Max: 11.02
Current: 10.48
0.15
11.02
Shiller PE Ratio 30.73
HUM's Shiller PE Ratio is ranked lower than
62% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 27.81 vs. HUM: 30.73 )
Ranked among companies with meaningful Shiller PE Ratio only.
HUM' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.62  Med: 21.52 Max: 71.51
Current: 30.73
10.62
71.51

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.54
HUM's Dividend Yield % is ranked lower than
87% of the 31 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. HUM: 0.54 )
Ranked among companies with meaningful Dividend Yield % only.
HUM' s Dividend Yield % Range Over the Past 10 Years
Min: 0.3  Med: 0.77 Max: 1.61
Current: 0.54
0.3
1.61
Dividend Payout Ratio 0.13
HUM's Dividend Payout Ratio is ranked higher than
83% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.25 vs. HUM: 0.13 )
Ranked among companies with meaningful Dividend Payout Ratio only.
HUM' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.09  Med: 0.14 Max: 0.21
Current: 0.13
0.09
0.21
3-Year Dividend Growth Rate -6.70
HUM's 3-Year Dividend Growth Rate is ranked lower than
75% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.70 vs. HUM: -6.70 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
HUM' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 14
Current: -6.7
0
14
Forward Dividend Yield % 0.59
HUM's Forward Dividend Yield % is ranked lower than
93% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.65 vs. HUM: 0.59 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.63
HUM's 5-Year Yield-on-Cost % is ranked lower than
90% of the 41 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.04 vs. HUM: 0.63 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
HUM' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.35  Med: 0.9 Max: 1.88
Current: 0.63
0.35
1.88
3-Year Average Share Buyback Ratio 1.00
HUM's 3-Year Average Share Buyback Ratio is ranked higher than
50% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.00 vs. HUM: 1.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HUM' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -2  Med: -0.4 Max: 3
Current: 1
-2
3

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 4.92
HUM's Price-to-Tangible-Book is ranked higher than
75% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.27 vs. HUM: 4.92 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
HUM' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.32  Med: 3.2 Max: 12.29
Current: 4.92
1.32
12.29
Price-to-Intrinsic-Value-Projected-FCF 1.21
HUM's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
59% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.04 vs. HUM: 1.21 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
HUM' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.3  Med: 0.93 Max: 2.07
Current: 1.21
0.3
2.07
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.11
HUM's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
80% of the 10 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.60 vs. HUM: 2.11 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.68
HUM's Price-to-Median-PS-Value is ranked lower than
82% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.23 vs. HUM: 1.68 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
HUM' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.37  Med: 1.02 Max: 13.28
Current: 1.68
0.37
13.28
Price-to-Peter-Lynch-Fair-Value 3.99
HUM's Price-to-Peter-Lynch-Fair-Value is ranked lower than
92% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.63 vs. HUM: 3.99 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
HUM' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.23  Med: 0.67 Max: 15.34
Current: 3.99
0.23
15.34
Price-to-Graham-Number 2.30
HUM's Price-to-Graham-Number is ranked higher than
83% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.77 vs. HUM: 2.30 )
Ranked among companies with meaningful Price-to-Graham-Number only.
HUM' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.65  Med: 1.64 Max: 6.81
Current: 2.3
0.65
6.81
Earnings Yield (Greenblatt) % 12.74
HUM's Earnings Yield (Greenblatt) % is ranked higher than
84% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.65 vs. HUM: 12.74 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
HUM' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -3390  Med: 27.9 Max: 4111
Current: 12.74
-3390
4111
Forward Rate of Return (Yacktman) % 11.10
HUM's Forward Rate of Return (Yacktman) % is ranked lower than
80% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.88 vs. HUM: 11.10 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
HUM' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 6.9  Med: 27.45 Max: 51.5
Current: 11.1
6.9
51.5

More Statistics

Revenue (TTM) (Mil) $54,341.00
EPS (TTM) $ 9.84
Beta0.78
Short Percentage of Float3.78%
52-Week Range $150.00 - 241.33
Shares Outstanding (Mil)144.31

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 53,928 56,362 59,225
EPS ($) 11.15 12.32 13.52
EPS without NRI ($) 11.15 12.32 13.52
EPS Growth Rate
(Future 3Y To 5Y Estimate)
19.90%
Dividends per Share ($) 1.47 1.48 1.60
» More Articles for HUM

Headlines

Articles On GuruFocus.com
GAMCO Analyst: Is VMware a Compelling Investment Idea in Data Infrastructure? Jun 26 2017 
Gabelli TV: 2017 American Water Works Annual Conference Recap Jun 26 2017 
Monthly Dividend Stocks to Pay Your Bills Jun 26 2017 
The Rubicon Project: Who Is Selling and Why It's Creating a Bargain Price Jun 26 2017 
Sports, Stocks and the Magic Quadrants Jun 26 2017 
GMO Global Equity Insights - Whiplash: On Value, Growth and Ignoring the Fundamentals Jun 26 2017 
Dan Loeb's Third Point Letter on $3.5 Billion Nestle Purchase, Plans to Sells L'Oreal Jun 26 2017 
Canaries in the Coal Mine – What to Watch as Stocks Continue to Make New Highs Jun 26 2017 
A Look at Darden Valuation Jun 26 2017 
Is Dollar Tree Oversold With Potential Cuts to SNAP? Jun 26 2017 

More From Other Websites
CBO Predictions About The Senate Health Care Bill Are Deeply Flawed Jun 27 2017
Trading the CBO: 6 buys in healthcare Jun 26 2017
Senate Republicans Release Revised Version of Healthcare Bill Jun 26 2017
Here's What to Watch as the Senate Fights Over Healthcare Reform Jun 24 2017
Movement at the FTC Is Bad News for Rite Aid Jun 23 2017
Health care on pace from best week of the year Jun 23 2017
'Walmart Rx' Takes Center Stage as Walgreens Rite Aid Saga Nears Long Overdue End Jun 23 2017
White House Confident Healthcare Bill Passes Before August Recess Jun 23 2017
Humana Names Sam Deshpande Chief Risk Officer Jun 23 2017
Yahoo Finance Live: Market Movers - Jun 23rd, 2017 Jun 23 2017
Healthcare stocks are rallying after Senate GOP leaders unveil health care plan Jun 22 2017
Humana takes center stage in Walgreens/Rite Aid merger Jun 21 2017
Government health insurance markets holding up--barely Jun 21 2017
Cigna's 2017 growth may include Medicare Advantage acquisitions Jun 21 2017
Humana Honored as Silver and Bronze Stevie® Award Winner in 2017 American Business AwardsSM Jun 21 2017
Anthem Blue Cross Exits Obamacare In Two More Red States Jun 21 2017
Humana resists FTC subpoena, holding up Walgreens-Rite Aid merger Jun 21 2017
S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017 Jun 21 2017
Humana Pushes Back Against FTC Subpoena Tied to Walgreens, Rite Aid Deal Jun 21 2017
Recipe for Success: Humana Healthier Choices Program Celebrates 10 Years of Improving Health at... Jun 21 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}